Markets›ADXN

Addex Therapeutics Ltd.

ADXN
3.65
+0.19 (+5.49%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value6.22M

Profitability (last 12 months)

Net income6.48M
Return on assets76.2%

Balance sheet (latest quarter)

Cash and equivalents2.30M

Per share and dividends

Shares outstanding147.83M
Dividends paid (last 12 months)None

Trading

Price3.65
52-week high11.97
52-week low3.10
1-year price change-59.17%
Average volume (3 months)188.9K
Beta against the S&P 500 (1 year)0.79

Calculated from Addex Therapeutics Ltd.'s SEC filings (latest quarter ending Jun 30, 2025) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.